journal articleLitStream CollectionGreater understanding about interpreting the Recap of atopic eczema (RECAP) questionnaire2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad359pmid: 37879739
journal articleLitStream CollectionUnderstanding the biology of cutaneous squamous cell carcinoma2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad355pmid: 37879741
journal articleLitStream CollectionComparison of biologic treatments in psoriasis using treatment duration2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad356pmid: 37879740
journal articleLitStream CollectionViews on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad350pmid: 37879743
journal articleLitStream CollectionCorrection to: TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad346pmid: 37742065
journal articleLitStream CollectionComparison of risankizumab with apremilast for the treatment of moderate psoriasis2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad349pmid: 37879737
journal articleLitStream CollectionMultiple skin lesions, especially on the legs, predict a poorer prognosis in skin lymphoma with large tumour cells2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad354pmid: 37879748
journal articleLitStream CollectionCorrection to: Partner bereavement and risk of psoriasis and atopic eczema: cohort studies in the U.K. and Denmark, and to: Partner bereavement and risk of chronic urticaria, alopecia areata and vitiligo: cohort studies in the UK and Denmark2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad338pmid: 37708291
journal articleLitStream CollectionLifetime burden of Stevens–Johnson syndrome/toxic epidermal necrolysis2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad352pmid: 37879747
journal articleLitStream CollectionSafety and effectiveness of amlitelimab, a potential new treatment for atopic dermatitis: results of a clinical trial2023 British Journal of Dermatologydoi: 10.1093/bjd/ljad357pmid: 37879745